BDRX·59564R880·US·adr·Healthcare - Biotechnology-13D/G
BDRX (BIODEXA PHARMACEUTICALS PLC ADR) is held by 2 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($78), RHUMBLINE ADVISERS ($11). Net institutional sentiment: Bearish.
See how BDRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer